An abortion provider and lawmakers in North Carolina are pushing a federal judge to decide if new state restrictions on the use of an abortion-inducing drug can survive in light of a federal regulatory scheme covering the medication.
The federal Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for mifepristone preempts
North Carolina’s latest anti-abortion statute, physician Amy Bryant and state Attorney General Josh Stein (D) told the US District Court for the Middle District of North Carolina in separate post-hearing briefs Monday.
The state law, however, “works in tandem” with the federal Food and Drug Administration’s regulations to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.